942 / 1631
1
Combined DLBCL and FL cohorts
2
Peripheral neuropathy reported by MedRA SMQ (Standardized MedRa Query)
Adverse Events at Rate ≥20% by Treatment Group
1
▪
SAEs occurred more frequently in pola-BR (33% BR vs 55% pola-BR)
–
Most common were infections (18% vs 23%) and febrile neutropenia (3% vs 12%)
0
10
20
30
40
50
60
Grade
1
Grade
2
Grade
3
Grade
4
0
10
20
30
40
BR
Pola-BR
Neutropenia
Nausea
Diarrhea
Fatigue
Thrombocytopenia
Anemia
Pyrexia
Decreased
appetite
Peripheral neuropathy
2
90